国产中文无码av每日更新在线观看, 亚洲天堂中文字幕一区二区三区免费, 国产口爆吞精在线观视频-黄色国产, 92福利-国内精品久久久久久99,亚洲成AV人A片不卡无码,浪潮AV无码专区,老熟女败火白浆,中文字幕日产av,色情日本免费看大片

更新于 5月27日

(Associate) Director, DMPK Project Rep (MJ012643)

4-6.5萬·14薪
  • 北京昌平區(qū)
  • 5-10年
  • 博士
  • 全職
  • 招1人

職位描述

生物藥新藥
  • General Description:
  • The DMPK Department of BeiGene is seeking a highly motivated individual to join the Project Rep group. The successful candidate will have extensive experiences in supporting small as well as large molecule projects with in-depth understanding of how to identify rate-limiting step and impact project team.
  • Serve as a DMPK representative on project teams and collaborate with project team members (e.g., Medicinal Chemistry, Discovery Biology, In vivo Pharmacology, Pre-clinical Safety, Clinical Pharmacology) and groups within DMPK-BA to generate relevant data to support compound progression.
  • Effectively communicate DMPK strategy and knowledge to project teams, functional leaders, and other key stakeholders to ensure alignment and influence decisions
  • Demonstrate thorough understanding of the ADME aspects necessary for the characterization of modalities to support regulatory submissions.
  • Coordinate and request DMPK studies in a timely manner and communicate protocols, timelines, needs and results back to team, ensuring optimized cycle times
  • Mentor junior project reps within the DMPK organization in approaches and best practices, ensuring that support is aligned with project and functional deliverables
  • Additional Job Description
  • Additional Job Description
  • Education Required:
  • A Ph.D. degree in pharmacokinetics, pharmacology, or pharmaceutical sciences with strong project rep experiences
百濟神州全球勝任力 當(dāng)我們通過以下十二項全球勝任力,展現(xiàn)出 "患者為先"、"無界協(xié)作"、"銳意創(chuàng)新 "和 "追求卓越 "的價值觀時,我們就能幫助全世界更多患者獲得更多負(fù)擔(dān)得起的藥品。 ? 團隊協(xié)作 ? 提供并征求坦誠及可行的反饋 ? 自我認(rèn)知 ? 兼容并蓄 ? 積極主動 ? 開拓精神 ? 持續(xù)學(xué)習(xí) ? 擁抱變化 ? 結(jié)果導(dǎo)向 ? 分析性思維/數(shù)據(jù)分析 ? 卓越財務(wù) ? 清晰溝通 BeiGene Global Competencies When we exhibit our values of Patients First, Collaborative Spirit, Bold Ingenuity and Driving Excellence, through our twelve global competencies below, we help get more affordable medicines to more patients around the world. ? Fosters Teamwork ? Provides and Solicits Honest and Actionable Feedback ? Self-Awareness ? Acts Inclusively ? Demonstrates Initiative ? Entrepreneurial Mindset ? Continuous Learning ? Embraces Change ? Results-Oriented ? Analytical Thinking/Data Analysis ? Financial Excellence ? Communicates with Clarity 求職者隱私申明: 百濟神州致力于尊重和保護(hù)您的個人信息權(quán)利,并承諾依據(jù)合法、正當(dāng)、必要和誠信的原則處理您的個人信息(包括個人敏感信息 )。 由于百濟神州在全球范圍內(nèi)開展業(yè)務(wù),我們可能需要基于人力資源管理等合理業(yè)務(wù)目的而將您的個人信息發(fā)送和/或存儲在位于您所在國家以外其他國家(例如:美國)的服務(wù)器和數(shù)據(jù)庫中,詳情參見百濟神州《求職者隱私政策》(百濟神州官網(wǎng) - 隱私政策 - 求職者隱私政策)。 如您主動向我們提供您的簡歷信息或其他個人信息,則視為您已經(jīng)充分理解并確認(rèn)接受百濟神州《求職者隱私政策》內(nèi)容。如您對此有任何疑問的,請勿提交簡歷信息或其他個人信息。 BeiGene is committed to respect and protect your personal information rights, and will process your personal information, including your sensitive personal information, based on the principles of legality, legitimacy, necessity, and integrity. Due to the reasonable business need for human resource management as a result of BeiGene’s global operation, your personal information may be transferred and/ or stored in a server/database located in a third country (e.g., the United States) other than your own country. For further details, please refer to BeiGene Job Applicant Privacy Policy (BeiGene official website - Privacy Policy - Job Applicant Privacy Policy). If you voluntarily provide your resume or other personal information to us, it is deemed as you have thoroughly acknowledged and accepted BeiGene Job Applicant Privacy Policy. If you have any concern, please DO NOT submit your resume or any other personal information.

工作地點

北京市昌平區(qū)科學(xué)園路30號

職位發(fā)布者

張婧媛/百濟神州研發(fā)招聘recruiter

當(dāng)前在線
立即溝通
公司Logo百濟神州北京
About BeiGene BeiGene is a publically traded(BGNE, NASDAQ), globally focused biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer. Our cancer biology platform addresses the importance of tumor-immune system interactions and the value of primary tumor biopsies in developing new cancer models. We have a global team of over 200 individuals, including over 150 scientists and clinicians, and a world-renowned scientific advisory board, with deep scientific talent, extensive pharmaceutical experience, and a commitment to improving the lives of cancer patients around the world. Our clinical pipeline is comprised of novel oral small molecules and monoclonal antibodies(mAb) for cancer, including an anti-PD-1 monoclonal antibody, a best-in-class BTK inhibitor, a RAF dimer inhibitor, a best-in-class PARP inhibitor, and a variety of combination clinical studies. In addition, our robust preclinical programs are expected to generate more small molecule and mAb drugs for clinical development in coming years. For more information, please visit our website at www.beigene.com.
公司主頁